Chi­nese im­ports of com­mon can­cer drug run dry, FDA says

Chi­na’s Qilu Phar­ma­ceu­ti­cal has dis­trib­uted all of the chemother­a­py cis­platin that was im­port­ed as a re­sult of the short­age of the com­mon can­cer drug.

The an­nounce­ment was made via FDA’s drug short­age page for cis­platin as of Sept. 18. Oth­er up­dates from Mon­day in­clud­ed Fre­se­nius Kabi say­ing its sup­plies of the drug are on back­o­rder, but WG Crit­i­cal Care says it has some sup­plies un­der al­lo­ca­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER